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ABSTRACT
Objective To analyze the usefulness of transvaginal color
Doppler assessment of venous flow in the differential diag-
nosis of adnexal masses.
Material and Methods Ninety-one consecutive patients
(mean age: 46.6 years, range: 16–81 years) diagnosed as
having an adnexal mass were evaluated by transvaginal color
Doppler sonography prior to surgery. Color Doppler was
used to detect and analyze the flow velocity waveform from
arterial and venous blood flow within the tumor. For arterial
signals the resistance index and peak systolic velocity, and for
veins the maximum venous flow velocity, were calculated.
Receiver operator characteristic curves were plotted to
determine the best venous flow velocity cut-off. According
to our previous study using arterial Doppler, a tumor was
considered as malignant when flow was detected and the
lowest resistance index was ≤ 0.45. Using venous Doppler a
mass was considered as malignant when flow was detected
and the venous flow velocity was ≥ the best cut-off found
on the receiver operator characteristic curve. Definitive
histopathological diagnosis was obtained in all cases. Sens-
itivity, specificity, positive predictive value and negative
predictive value for B-mode morphology (evaluation per-
formed according to Sassone’s scoring system), arterial
Doppler, venous Doppler, and a combination of both arterial
and venous Doppler were calculated.
Results Twenty-five masses (27.5%) were malignant and 66
(72.5%) benign. Arterial and venous flow was found more
frequently in malignant than in benign masses (92% vs. 41%
(P < 0.001) and 72% vs. 21% (P < 0.001), respectively).
The resistance index was significantly lower in malignant
tumors (0.42 vs. 0.60, P = 0.0003). No differences were
found in peak systolic velocity. Venous flow velocity was
significantly higher in malignant masses (18.1 cm/s vs.
8.9 cm/s, P = 0.0006). The best cut-off of venous flow
velocity was 10 cm/s. Sensitivity, specificity, positive pre-
dictive value and negative predictive value for morphology,
arterial Doppler, venous Doppler, and the combination of
both arterial and venous Doppler were 92%, 71%, 45%,
96%; 76%, 95%, 87%, 91%; 68%, 94%, 81%, 89%; and
88%, 91%, 79%, 95%, respectively.
Conclusions Our results indicate that preoperative evaluation
by venous flow assessment of adnexal masses may be useful
to discriminate between malignant and benign tumors.
INTRODUCTION
Since the introduction of transvaginal color Doppler sono-
graphy in the assessment of ovarian tumor vascularity1, many
studies concerning its usefulness to discriminate between
malignant and benign adnexal masses have been reported.
Although some authors have found this technique useful2–10,
others have questioned these results11–17.
All these studies have focused on the evaluation of arterial
blood flow in the adnexal mass, trying to find differences in
blood flow impedance or arterial systolic velocity between
benign and malignant tumors based on the vascular changes
in malignant tumors due to neoangiogenesis18.
However, to the best of our knowledge, no study has assessed
the role of venous flow in the differential diagnosis of adnexal
masses. The aim of this study was to evaluate venous flow
in a series of adnexal masses and to determine whether it
can be used to discriminate between malignant and benign
tumors.
MATERIALS AND METHODS
From June 1998 to May 1999, 180 consecutive patients dia-
gnosed as having an adnexal mass were evaluated by transvaginal
color Doppler sonography in our institution. Ninety-one
patients underwent surgical removal of the adnexal mass
during this period. This report is based on these 91 patients.
Patients’ age ranged from 16–81 years (mean age. 46.6 years,
SD: 14.1). Fifty-eight (63.7%) were premenopausal and 33
(36.3%) were postmenopausal.
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All patients underwent transvaginal color Doppler sono-
graphy within 1 week prior to surgery. Ultrasonic examina-
tions were performed using a Philips P700 SE machine (Philips
Ultrasound, Santa Ana, CA, USA) with a real-time 6.5-MHz
sector electronic array endovaginal probe with 5.0-MHz
pulsed Doppler system and equipped with the color velocity
imaging (CVI) system for color blood flow coding19. The
system operates at power outputs of less than 80 mW/cm2 in
the B-mode, pulsed Doppler and CVI modes. The high-pass
filter was set at 100 Hz and pulsed Doppler sample volume
was set at 1.2–2 mm width. Pulse repetition frequency was
set at 1.5–25 kHz.
Morphological evaluation of the adnexal masses was
performed according to Sassone’s scoring system20. Briefly, it
evaluates wall thickness (score 1–3), the presence of septa and
their thickness (score 1–3), inner wall structure (score 1–4),
and echogenicity (score 1–5). A combined score of 4–15 is
thus obtained. A score of ≥ 9 was considered as being sug-
gestive of malignancy.
Tumor volume was calculated according to the prolate
ellipse formula: length (cm) × height (cm) × width (cm) ×
0.5233, and expressed in mL.
After morphologic evaluation, the CVI gate was activated
to identify blood flow signals within the adnexal mass and
pulsed Doppler was used to analyze each color signal
detected. A flow velocity waveform (FVW) was obtained in
each case. We identified arterial and venous signals. Arterial
blood flow was characterized by a biphasic FVW with a
systolic and a diastolic component (Figure 1), whereas venous
flow was characterized by a monophasic continuous flow
(Figure 2). From arterial signals blood flow impedance was
estimated by calculating the resistance index (RI = (maximum
systolic velocity – end diastolic velocity)/maximum systolic
velocity) from three consecutive FVWs. The lowest RI found
after every color spot had been interrogated was analyzed.
Peak systolic velocity (PSV, cm/s) was also recorded in each
vessel. From venous signals only maximum velocity was
calculated, the venous flow velocity (VFV, cm/s). In those
tumors with more than one venous vessel detected, that with
the highest VFV was analyzed. No angle correction was
made because the vessels studied were too small to allow this,
although we always tried to obtain the highest Doppler shift
to measure the velocity.
All ultrasound examinations were performed by one of the
authors (J.L.A.). From a previous study we estimated an
intraobserver coefficient of variation for RI and PSV of 6%
and 12%, respectively21. The coefficient of variation for VFV
and the number of venous vessels within a given tumor was
calculated in the first 10 patients by performing two exam-
inations with a 10-min interval between examinations.
Color and pulsed Doppler evaluation was performed, measur-
ing the number of vessels detected and VFV. The coefficient
of variation for VFV and number of venous vessels were 8%
and 4%, respectively.
All patients underwent surgical removal of the adnexal
mass and definitive histopathological diagnosis was obtained
in every case. Surgeons were blinded to the results of flow
studies. Tumors were classified according to the World Health
Organization22. Ovarian malignancies were staged according
to the FIGO23. Low grade (borderline) malignant tumors
were considered as malignant masses for statistical analysis.
The Kolmogorov–Smirnov test was used to determine
normal distribution of continuous variables. Data were
expressed as mean and standard deviation (SD) or median
with interquartile range (IQR) where appropriate. One-way
analysis of variance or Mann–Whitney U-tests were used to
compare continuous variables, where appropriate. Fisher’s
exact test was used to compare categorical variables. All tests
were two-tailed. Receiver operator characteristic (ROC) curves
were plotted to determine the best cut-off of VFV and PSV to
differentiate benign from malignant adnexal masses, and to
confirm whether the pre-established RI cut-off was the best one.
The area under the curve was calculated for each parameter.
Sensitivity, specificity, positive predictive value (PPV) and
negative predictive value (NPV) for morphological scoring
system (Morphology), arterial Doppler (AD), and venous
Doppler (VD) were calculated. Sensitivity and specificity were
compared using the McNemar test. We further calculated
Figure 1 Sonogram showing a characteristic arterial biphasic flow 
velocity waveform from an arterial vessel, with a systolic and a diastolic 
component, obtained from a left-sided cystic adnexal mass.
Figure 2 The same case as in Figure 1 showing a characteristic venous 
monophasic flow velocity waveform, with continuous flow, obtained 
from a venous vessel.
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the sensitivity, specificity, PPV and NPV for a combination
of arterial and venous flow (AVD), when arterial or venous
Doppler suggested malignancy.
According to our previous study, arterial Doppler findings
were considered as suggestive of malignancy when arterial
flow was detected and the lowest RI found was ≤ 0.4521.
Venous Doppler was considered as suggestive of malignancy
when venous flow was detected and the highest VFV found
was ≥ to the best cut-off found on the ROC curve.
The 95% confidence intervals were calculated where
appropriate.
A P-value of < 0.05 was considered as statistically significant.
All statistical analyses were performed using the SPSS
(Statistical package for the Social Sciences) version 6.0 for
Windows (SPSS Inc., Chicago, IL, USA).
RESULTS
Twenty-five (27.5%) masses were found to be malignant and
66 (72.5%) were benign (Table 1). Stages of primary ovarian
malignancies were as follows: stage I: five (23%); stage III: 13
(59%) and stage IV: four (18%).
Arterial blood flow was found in 92% (23/25) of malignant
tumors as compared with 41% (27/66) of benign tumors
(P < 0.001). Venous flow was found in 72% (18/25) of
malignant masses, whereas it was found in 21% (14/66) of
benign masses (P < 0.001).
Median tumor volume in malignant masses (267.9 mL,
IQR: 498.1) was significantly higher than in benign tumors
(63.7 mL, IQR: 145.5, P = 0.012),
Venous flow velocity was significantly higher in malignant
tumors. No differences were found in PSV (Table 2). The
numbers of arterial and venous vessels were significantly higher
in malignant tumors (Table 2).
In malignant masses, mean RI and mean score were significantly
lower and higher, respectively, than in benign tumors (Table 2).
Receiver operator characteristic curve analysis revealed
that the best VFV cut-off was 10 cm/s, with a sensitivity of
94% and specificity of 71%(Figure 3).
Sensitivity and specificity for morphology, AD, VD and
AVD are shown in Table 3. Both AD and VD had similar
performance. However, both techniques had significantly
higher specificity than morphology, but morphology was more
sensitive. Combined AVD had increased sensitivity with no
decrease in specificity; the combination had similar sensitivity
but significantly higher specificity than morphology alone.
Table 1 Histopathologic diagnosis in 91 adnexal masses
Histology n %
Endometrioma 16 17.6
Serous cystadenoma 14 15.4
Mature teratoma 9 9.9
Mucinous cystadenoma 4 4.4
Cystadenofibroma 5 5.5
Paraovarian cyst 3 3.3
Fibrothecoma 3 3.3
Follicular cyst 2 2.2
Hemorrhagic cyst 3 3.3
Hydrosalpinx 1 1.1
Mesotelial cyst 1 1.1
Tubo-ovarian abscess 2 2.2
Struma ovarii 2 2.2
Leiomyoma 1 1.1
Low malignant potential tumors 2 2.2
Primary cystadenocarcinoma 20 22.0
Metastatic carcinoma 3 3.3
Table 2 Sonographic and Doppler parameters in malignant and benign 
masses
Benign Malignant P-value
Sassone’s score 6.9 (2.5) 10.9 (1.7) < 0.0001
Lowest RI 0.60 (0.1) 0.42 (1.7)  0.0003
PSV (cm/s) 29.1 (22.2) 31.2 (22.9)  0.745
VFV (cm/s) 8.9 (8.9) 18.1 (9.5)  0.0006
Number of arterial vessels 0.55 (0.2) 2.3 (1.7) < 0.001
Number of venous vessels 1.5 (1.2) 3.1 (1.2) < 0.001
Data expressed as means (standard deviations in parentheses). RI, 
resistance index; PSV, peak systolic velocity; VFV, venous flow velocity.
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Figure 3 Receiver operator characteristic curves for venous flow 
velocity (, area under the curve: 0.859; standard error: 0.06), peak 
systolic velocity (H17009, area under the curve: 0.512; standard error: 0.09) 
and lowest resistance index (, area under the curve: 0.828; standard 
error: 0.06).
Table 3 Sensitivity and specificity for morphology, arterial Doppler, 
venous Doppler and combined arterial and venous Doppler
Sensitivity (%)* Specificity (%)†
Morphologya 92.0 (74.9–99.6) 71.2 (58.7–81.7)
Arterial Dopplerb 76.0 (54.9–90.6) 95.5 (87.3–99.0)
Venous Dopplerc 68.0 (46.5–85) 93.9 (85.2–98.3)
Arterial and venous Dopplerd 88.0 (68.8–97.1) 90.9 (81.2–96.6)
95% confidence intervals in parentheses; *a vs. b: P < 0.0001; a vs. c: 
P < 0.0001; a vs. d: P = NS; b vs. c: P = NS; b vs. d: P = 0.031; c vs. d: 
P = 0.016; †a vs. b: P < 0.0001; a vs. c: P < 0.0001; a vs. d: P < 0.0001; 
b vs. c: P = NS; b vs. d: P = NS; c vs. d: P = NS; NS, not significant.
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The PPVs and NPVs for morphology, AD, VD and AVD
were: 45% and 96%; 87% and 91%; 81% and 89%; 79%
and 95%, respectively.
DISCUSSION
Transvaginal color Doppler assessment of adnexal masses
was used in an attempt to improve the diagnostic accuracy of
ultrasound in determining the nature, benign or malignant,
of these masses. The rationale for using this technique was
based on the fact that Doppler allows the assessment of angio-
genesis in vivo as demonstrated by Ramos et al.24 and Dock
et al.25. Angiogenesis is an essential event in malignant tumor
growth in which new vessels are formed within the tumor
allowing the supply of oxygen and nutrients to tumoral cells.
This new vascular network consists of venulae, capillaries
and arteriovenous shunts. The neovascularized arterioles are
characterized by a paucity or absence of the muscular media.
These vascular changes can be detected by Doppler, showing
a significant decreased impedance to flow distal to the point
of measurement26.
Since the pioneering report of Kurjak and coworkers1,
many studies have been published in recent years assessing
the value of transvaginal color Doppler to differentiate between
malignant and benign adnexal masses. The results have been
controversial. Some authors have found this technique useful2–10,
whereas others have not11–17. Some factors put forward to
explain these conflicting results include differences in sonog-
raphers’ experience, different sensitivity in ultrasound machines
and the lack of standarization of Doppler measurements27.
All these studies have focused only on arterial vessels assessing
blood flow impedance, by calculating two angle-independent
indices of FVW spectral analysis (RI and PI) and the PSV.
This simple assessment of arterial flow might also help to
explain these controversial results. Thus, more complex multi-
parameter analysis28, scoring systems29 and logistic models30
have been proposed.
To the best of our knowledge, however, no study has
analyzed the role of venous blood flow in discriminating
between malignant and benign adnexal masses. Our results
indicate that malignant tumors show venous vessels in a
higher percentage of cases than do benign tumors. We also
found that VFV was significantly higher in malignant than in
benign masses.
Diagnostic performance of venous flow assessment was
similar to that of arterial flow, and more specific but also
significantly less sensitive than morphologic evaluation.
Doppler was significantly more specific than morphologic
evaluation with comparable sensitivity, when an adnexal mass
was considered as suggestive of malignancy when arterial
flow was found and the lowest RI was ≤ 0.45 or when venous
flow was present and flow velocity was ≥ 10 cm/s. Notwith-
standing, we think that morphologic assessment should
remain the major diagnostic criterion in sonographic evalu-
ation of adnexal masses, due to its high sensitivity, with
Doppler assessment an adjuvant tool to reduce the false-
positive rate.
These results indicate that the addition of venous flow
assessment to conventional arterial evaluation may increase
the diagnostic performance of Doppler ultrasound in the
differentiation of malignant from benign adnexal masses.
Venous flow assessment is simple, since it involves evaluation
of only one parameter. Furthermore, VFV estimation seemed
to be reproducible.
In conclusion, we have evaluated the role of transvaginal
color Doppler assessment of venous flow in adnexal masses.
Our results indicate that malignant tumors are characterized
by higher venous blood flow velocities than benign tumors
and that measurement of VFV may be used for discriminating
between benign and malignant adnexal masses. This should,
however, be cross-validated prospectively.
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